Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease

Mise à jour : Il y a 4 ans
Référence : NCT00174239

Femme et Homme

Extrait

The study will assess the relative benefit of cabergoline vs carbidopa/levodopa therapy in treating nighttime problems of Parkinson Disease.


Critère d'inclusion

  • Parkinson disease

Liens